The USFDA has granted final approval for Lupin Pharmaceuticals, Inc.’s Abbreviated New Drug Application (ANDA) for Sertraline Hydrochloride Tablets, 25mg, 50mg and 100mg.
The company’s Sertraline Tablets are the AB-rated generic equivalent of Pfizer's Zoloft® Tablets that are indicated for the treatment of major depressive disorder.
Lupin Pharmaceuticals, Inc. is the U.S. wholly owned subsidiary of Lupin Limited (BOM: 500257) – one of the top five Pharmaceutical companies in India headquartered in Mumbai.
Read the full press release.
[Photo Credit: 77 Canada Pharmacy]
Comment Preview